MENU
+Compare
NVOX
ETF ticker: NYSE ARCA
AS OF
Sep 5 closing price
Price
$3.56
Change
-$0.13 (-3.52%)

NVOX stock forecast, quote, news & analysis

The investment seeks daily investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of NOVO Nordisk A/S - ADR (NYSE: NVO”)... Show more

Category: #Trading
NVOX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for NVOX with price predictions
Sep 05, 2025

NVOX saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for NVOX moved out of overbought territory on August 28, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 6 similar instances where the indicator exited the overbought zone. In of the 6 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 05, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NVOX as a result. In of 9 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVOX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NVOX broke above its upper Bollinger Band on August 18, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for NVOX entered a downward trend on August 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NVOX's RSI Indicator exited the oversold zone, of 7 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NVOX just turned positive on August 14, 2025. Looking at past instances where NVOX's MACD turned positive, the stock continued to rise in of 1 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NVOX advanced for three days, in of 35 cases, the price rose further within the following month. The odds of a continued upward trend are .

A.I.Advisor
published Highlights

Industry description

The investment seeks daily investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of NOVO Nordisk A/S - ADR (NYSE: NVO”). The fund is an actively managed exchange traded fund (“ETF”) that attempts to achieve two times (200%) the daily percentage change in the share price of the underlying security by employing derivatives, namely swap agreements and/or listed options contracts. The fund is non-diversified.

High and low price notable news

The average weekly price growth across all stocks in the Defiance Daily Target 2X Long NVO ETF ETF was -5%. For the same ETF, the average monthly price growth was 45%, and the average quarterly price growth was -69%. NVO experienced the highest price growth at -2%, while NVO experienced the biggest fall at -2%.
View a ticker or compare two or three
NVOX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Fundamentals
Details